Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00819507Phase 4Completed
A Phase 4 trial of fluocinonide in atopic dermatitis (AD), sponsored by Oregon Health & Science University. Started Jan 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00819507.